Page last updated: 2024-08-24

3-iodobenzylguanidine and Dyslipidemias

3-iodobenzylguanidine has been researched along with Dyslipidemias in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ascaso, JF; Carmena, R; Civera, M; Molina, M; Navarro, I; Real, JT	1

Reviews

1 review(s) available for 3-iodobenzylguanidine and Dyslipidemias

Article	Year
[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:4 Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamines; Combined Modality Therapy; Diagnosis, Differential; Dyslipidemias; Female; Humans; Hypertension; Metanephrine; Middle Aged; Myocardial Infarction; Phenoxybenzamine; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Vanilmandelic Acid; Ventricular Dysfunction, Left	2011

Article

Year

[Catecholamine-induced cardiomyopathy triggered by pheochromocytoma].

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2011, Volume: 58, Issue:4

Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Adrenal Gland Neoplasms; Adrenalectomy; Catecholamines; Combined Modality Therapy; Diagnosis, Differential; Dyslipidemias; Female; Humans; Hypertension; Metanephrine; Middle Aged; Myocardial Infarction; Phenoxybenzamine; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Vanilmandelic Acid; Ventricular Dysfunction, Left

2011